Global Information
회사소개 | 문의 | 비교리스트

세계의 마이크로플루이딕스 시장(2021-2025년)

Global Microfluidics Market 2021-2025

리서치사 TechNavio (Infiniti Research Ltd.)
발행일 2021년 12월 상품코드 1043444
페이지 정보 영문 120 Pages 배송안내
가격
US $ 2,500 ₩ 3,185,000 PDF (Single User License) help
1명만 이용할 수 있는 라이선스입니다. PDF 파일은 Copy & Paste가 가능합니다. 인쇄횟수에 제한은 없으나, 인쇄물의 이용 범위는 PDF 이용 범위에 준합니다.
US $ 3,000 ₩ 3,822,000 PDF (5-user License) help
동일 사업장 내 5명까지 공유하여 이용할 수 있는 라이선스입니다. PDF 파일은 Copy & Paste가 가능합니다. 인쇄횟수에 제한은 없으나, 인쇄물의 이용 범위는 PDF 이용 범위에 준합니다.
US $ 4,000 ₩ 5,096,000 PDF (Enterprise License) help
동일 기업 내 모든 분들이 공유하여 이용할 수 있는 라이선스입니다. 이용 인원수에 제한은 없습니다. PDF 파일은 Copy & Paste가 가능합니다. 인쇄횟수에 제한은 없으나, 인쇄물의 이용 범위는 PDF 이용 범위에 준합니다.
US $ 5,000 ₩ 6,371,000 PDF (Global License) help
동일 기업 내 모든 분들이 공유하여 이용할 수 있는 라이선스입니다. 이용 인원수에 제한은 없습니다. PDF 파일은 Copy & Paste가 가능합니다. 인쇄횟수에 제한은 없으나, 인쇄물의 이용 범위는 PDF 이용 범위에 준합니다. 또한 해당 라이선스는 보고서 컨텐츠의 15% 이내로 외부용 문서에 인용 게재가 허용됩니다(예:프레스릴리스, 마케팅 자료, 백서 등).


세계의 마이크로플루이딕스 시장(2021-2025년) Global Microfluidics Market 2021-2025
발행일 : 2021년 12월 페이지 정보 : 영문 120 Pages

본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문목차를 참고해주시기 바랍니다.

세계의 마이크로플루이딕스 시장 규모는 2021-2025년간 432억 7,000만 달러 확대될 전망이며, 예측기간 중 19.81%의 연평균 복합 성장률(CAGR)을 나타낼 것으로 예상됩니다.

세계의 마이크로플루이딕스(Microfluidics) 시장에 대해 조사분석했으며, 시장 구도, 시장 규모, 시장 분석, 고객 상황, 벤더 구도, 벤더 분석 등의 정보를 전해드립니다.

목차

개요

시장 구도

  • 시장 생태계
  • 밸류체인 분석

시장 규모

  • 시장의 정의
  • 시장 부문 분석
  • 시장 규모(2020년)
  • 시장 전망 : 예측(2020-2025년)

Five Forces 분석

  • Five Forces 요약
  • 바이어의 교섭력
  • 공급 기업의 교섭력
  • 신규 진출업체의 위협
  • 대체품의 위협
  • 경쟁 기업의 위협
  • 시장 현황

시장 세분화 : 용도별

  • 시장 세분화
  • 비교 : 용도별
  • 체외진단 : 시장 규모와 예측(2020-2025년)
  • 제약 연구 : 시장 규모와 예측(2020-2025년)
  • 약물전달 서비스 : 시장 규모와 예측(2020-2025년)
  • 시장 기회 : 용도별

고객 상황

상황 : 지역별

  • 세분화 : 지역별
  • 비교 : 지역별
  • 북미 : 시장 규모와 예측(2020-2025년)
  • 유럽 : 시장 규모와 예측(2020-2025년)
  • 아시아태평양 : 시장 규모와 예측(2020-2025년)
  • 남미 : 시장 규모와 예측(2020-2025년)
  • 중동 및 아프리카 : 시장 규모와 예측(2020-2025년)
  • 주요 국가
  • 시장 기회 : 지역 상황별
  • 시장 성장 촉진요인
  • 시장이 해결해야 할 과제
  • 시장 동향

벤더 구도

  • 개요
  • 벤더 구도
  • 창조적 파괴 상황

벤더 분석

  • 대상 벤더
  • 벤더의 시장 포지셔닝
  • Agilent Technologies Inc.
  • Bio Rad Laboratories Inc.
  • Biocartis Group NV
  • BioFluidix GmbH
  • Danaher Corp.
  • Fluigent SA
  • General Electric Co.
  • PerkinElmer Inc.
  • QIAGEN NV
  • uFluidix Inc.

부록

LSH 22.01.06

Global Microfluidic Market For Healthcare Application 2021-2025

Technavio has been monitoring the microfluidic market for healthcare application and it is poised to grow by $ 43.27 bn during 2021-2025, progressing at a CAGR of 19.81% during the forecast period. Our report on the microfluidic market for healthcare application provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by the compact size of microfluidic devices and growth in lifestyle diseases. In addition, compact size of microfluidic devices is anticipated to boost the growth of the market as well.

The microfluidic market for healthcare application analysis includes the application segment and geographic landscape.

Technavio's microfluidic market for healthcare application is segmented as below:

By Application

  • In-vitro diagnostics
  • Pharmaceutical research
  • Drug delivery services

By Geographical Landscape

  • North America
  • Europe
  • APAC
  • South America
  • MEA

This study identifies the advances in DNA sequencingas one of the prime reasons driving the microfluidic market for healthcare application growth during the next few years.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters. Our report on microfluidic market for healthcare application covers the following areas:

  • Microfluidic market for healthcare application sizing
  • Microfluidic market for healthcare application forecast
  • Microfluidic market for healthcare application industry analysis

Technavio's robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading microfluidic market for healthcare application vendors that include Agilent Technologies Inc., Bio Rad Laboratories Inc., Biocartis Group NV, BioFluidix GmbH, Danaher Corp., Fluigent SA, General Electric Co., PerkinElmer Inc., QIAGEN NV, and uFluidix Inc. Also, the microfluidic market for healthcare application analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. Technavio's market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

Table of Contents

  • Executive Summary
    • Market Overview
  • Market Landscape
    • Market ecosystem
    • Value chain analysis
  • Market Sizing
    • Market definition
    • Market segment analysis
    • Market size 2020
    • Market outlook: Forecast for 2020 - 2025
  • Five Forces Analysis
    • Five forces summary
    • Bargaining power of buyers
    • Bargaining power of suppliers
    • Threat of new entrants
    • Threat of substitutes
    • Threat of rivalry
    • Market condition
  • Market Segmentation by Application
    • Market segments
    • Comparison by Application
    • In-vitro diagnostics - Market size and forecast 2020-2025
    • Pharmaceutical research - Market size and forecast 2020-2025
    • Drug delivery services - Market size and forecast 2020-2025
    • Market opportunity by Application
  • Customer landscape
  • Geographic Landscape
    • Geographic segmentation
    • Geographic comparison
    • North America - Market size and forecast 2020-2025
    • Europe - Market size and forecast 2020-2025
    • APAC - Market size and forecast 2020-2025
    • South America - Market size and forecast 2020-2025
    • MEA - Market size and forecast 2020-2025
    • Key leading countries
    • Market opportunity By Geographical Landscape
    • Market drivers
    • Market challenges
    • Market trends
  • Vendor Landscape
    • Overview
    • Vendor landscape
    • Landscape disruption
  • Vendor Analysis
    • Vendors covered
    • Market positioning of vendors
    • Agilent Technologies Inc.
    • Bio Rad Laboratories Inc.
    • Biocartis Group NV
    • BioFluidix GmbH
    • Danaher Corp.
    • Fluigent SA
    • General Electric Co.
    • PerkinElmer Inc.
    • QIAGEN NV
    • uFluidix Inc.
  • Appendix
    • Scope of the report
    • Currency conversion rates for US$
    • Research methodology
    • List of abbreviations

Exhibits

Exhibits1: Key Finding 1

Exhibits2: Key Finding 2

Exhibits3: Key Finding 3

Exhibits4: Key Finding 5

Exhibits5: Key Finding 6

Exhibits6: Key Finding 7

Exhibits7: Key Finding 8

Exhibits8: Parent market

Exhibits9: Market characteristics

Exhibits10: Offerings of vendors included in the market definition

Exhibits11: Market segments

Exhibits12: Global - Market size and forecast 2020 - 2025 ($ million)

Exhibits13: Global market: Year-over-year growth 2020 - 2025 (%)

Exhibits14: Five forces analysis 2020 & 2025

Exhibits15: Bargaining power of buyers

Exhibits16: Bargaining power of suppliers

Exhibits17: Threat of new entrants

Exhibits18: Threat of substitutes

Exhibits19: Threat of rivalry

Exhibits20: Market condition - Five forces 2020

Exhibits21: Application - Market share 2020-2025 (%)

Exhibits22: Comparison by Application

Exhibits23: In-vitro diagnostics - Market size and forecast 2020-2025 ($ million)

Exhibits24: In-vitro diagnostics - Year-over-year growth 2020-2025 (%)

Exhibits25: Pharmaceutical research - Market size and forecast 2020-2025 ($ million)

Exhibits26: Pharmaceutical research - Year-over-year growth 2020-2025 (%)

Exhibits27: Drug delivery services - Market size and forecast 2020-2025 ($ million)

Exhibits28: Drug delivery services - Year-over-year growth 2020-2025 (%)

Exhibits29: Market opportunity by Application

Exhibits30: Customer landscape

Exhibits31: Market share By Geographical Landscape 2020-2025 (%)

Exhibits32: Geographic comparison

Exhibits33: North America - Market size and forecast 2020-2025 ($ million)

Exhibits34: North America - Year-over-year growth 2020-2025 (%)

Exhibits35: Europe - Market size and forecast 2020-2025 ($ million)

Exhibits36: Europe - Year-over-year growth 2020-2025 (%)

Exhibits37: APAC - Market size and forecast 2020-2025 ($ million)

Exhibits38: APAC - Year-over-year growth 2020-2025 (%)

Exhibits39: South America - Market size and forecast 2020-2025 ($ million)

Exhibits40: South America - Year-over-year growth 2020-2025 (%)

Exhibits41: MEA - Market size and forecast 2020-2025 ($ million)

Exhibits42: MEA - Year-over-year growth 2020-2025 (%)

Exhibits43: Key leading countries

Exhibits44: Market opportunity By Geographical Landscape ($ million)

Exhibits45: Impact of drivers and challenges

Exhibits46: Vendor landscape

Exhibits47: Landscape disruption

Exhibits48: Industry risks

Exhibits49: Vendors covered

Exhibits50: Market positioning of vendors

Exhibits51: Agilent Technologies Inc. - Overview

Exhibits52: Agilent Technologies Inc. - Business segments

Exhibits53: Agilent Technologies Inc. - Key offerings

Exhibits54: Agilent Technologies Inc. - Key customers

Exhibits55: Agilent Technologies Inc. - Segment focus

Exhibits56: Bio Rad Laboratories Inc. - Overview

Exhibits57: Bio Rad Laboratories Inc. - Business segments

Exhibits58: Bio Rad Laboratories Inc. - Key offerings

Exhibits59: Bio Rad Laboratories Inc. - Key customers

Exhibits60: Bio Rad Laboratories Inc. - Segment focus

Exhibits61: Biocartis Group NV - Overview

Exhibits62: Biocartis Group NV - Business segments

Exhibits63: Biocartis Group NV - Key offerings

Exhibits64: Biocartis Group NV - Key customers

Exhibits65: Biocartis Group NV - Segment focus

Exhibits66: BioFluidix GmbH - Overview

Exhibits67: BioFluidix GmbH - Product and service

Exhibits68: BioFluidix GmbH - Key offerings

Exhibits69: BioFluidix GmbH - Key customers

Exhibits70: BioFluidix GmbH - Segment focus

Exhibits71: Danaher Corp. - Overview

Exhibits72: Danaher Corp. - Business segments

Exhibits73: Danaher Corp. - Key offerings

Exhibits74: Danaher Corp. - Key customers

Exhibits75: Danaher Corp. - Segment focus

Exhibits76: Fluigent SA - Overview

Exhibits77: Fluigent SA - Product and service

Exhibits78: Fluigent SA - Key offerings

Exhibits79: Fluigent SA - Key customers

Exhibits80: Fluigent SA - Segment focus

Exhibits81: General Electric Co. - Overview

Exhibits82: General Electric Co. - Business segments

Exhibits83: General Electric Co. - Key offerings

Exhibits84: General Electric Co. - Key customers

Exhibits85: General Electric Co. - Segment focus

Exhibits86: PerkinElmer Inc. - Overview

Exhibits87: PerkinElmer Inc. - Business segments

Exhibits88: PerkinElmer Inc. - Key offerings

Exhibits89: PerkinElmer Inc. - Key customers

Exhibits90: PerkinElmer Inc. - Segment focus

Exhibits91: QIAGEN NV - Overview

Exhibits92: QIAGEN NV - Business segments

Exhibits93: QIAGEN NV - Key offerings

Exhibits94: QIAGEN NV - Key customers

Exhibits95: QIAGEN NV - Segment focus

Exhibits96: uFluidix Inc. - Overview

Exhibits97: uFluidix Inc. - Product and service

Exhibits98: uFluidix Inc. - Key offerings

Exhibits99: uFluidix Inc. - Key customers

Exhibits100: uFluidix Inc. - Segment focus

Exhibits101: Currency conversion rates for US$

Exhibits102: Research Methodology

Exhibits103: Validation techniques employed for market sizing

Exhibits104: Information sources

Exhibits105: List of abbreviations

Back to Top
전화 문의
F A Q